Lobbying client

MARATHON PHARMACEUTICALS, LLC

Manufacturing Pharmaceuticals

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
13
Filed by
3
Reported in-house
—
Reported by firms
$220,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2014 to 2017

Filings

13 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2017
PODESTA GROUP, INC. $20,000 reported
1st Quarter - Report
1st Quarter 2017
PODESTA GROUP, INC. $50,000 reported
4th Quarter - Report
4th Quarter 2016
PODESTA GROUP, INC. $30,000 reported
3rd Quarter - Report
3rd Quarter 2016
PODESTA GROUP, INC. $10,000 reported
Registration
3rd Quarter 2016
PODESTA GROUP, INC. — reported
4th Quarter - Termination
4th Quarter 2015
MEHLMAN CONSULTING, INC. $10,000 reported
4th Quarter - Reportreplaced
4th Quarter 2015
MEHLMAN CONSULTING, INC. $10,000 reported
Registration
4th Quarter 2015
MEHLMAN CONSULTING, INC. — reported
1st Quarter - Termination
1st Quarter 2015
UPSTREAM CONSULTING $10,000 reported
4th Quarter - Report
4th Quarter 2014
UPSTREAM CONSULTING $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
PODESTA GROUP, INC. 4 $110,000
UPSTREAM CONSULTING 4 $100,000
MEHLMAN CONSULTING, INC. 1 $10,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 11
Pharmacy PHA 1

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2029 114th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.